Home
Hummingbird Bioscience

Hummingbird Bioscience Market Share Analysis for May 2026

Privacy Policy

Health > Biotechnology and Pharmaceuticals

Domainhummingbirdbioscience.com

Year Founded2015

Employees51 - 200

Annual Revenue$15M - $25M

Hummingbird Bioscience

Hummingbird Bioscience (including company regionals)

hummingbirdbioscience.com

See more website traffic and engagement information

Hummingbird Bioscience Revenue up to May 2026 is 15M - 25M

revenue generated by Hummingbird Bioscience top domains

Hummingbird Bioscience top domains revenue over 3 years

Revenue for Hummingbird Bioscience top domains

hummingbirdbioscience.com15M - 25M

See more with Sales Intelligence

Total visits to Hummingbird Bioscience's top domains

Understand Hummingbird Bioscience market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

hummingbirdbioscience.com6.1K

See more with Sales Intelligence

Avg. visit duration in Hummingbird Bioscience's top domains

Analyze Hummingbird Bioscience engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

hummingbirdbioscience.com00:00:59

See more with Sales Intelligence

Avg. pageviews on Hummingbird Bioscience's top domains

See how Hummingbird Bioscience keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

hummingbirdbioscience.com1.94

See more with Sales Intelligence

Hummingbird Bioscience top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Hummingbird Bioscience

These are the website technologies, by industry, used by Hummingbird Bioscience top domains

Widget (6)

Twemoji

Advertising (3)

Google Adsense

Payment & Currencies (3)

Cart Functionality

eCommerce (2)

WooCommerce

More Technologies

10

See all

News & Signals from Hummingbird Bioscience

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsHummingbird Bioscience Pte. Ltd. sold assets to Percheron Therapeutics Ltd in the amount of $290M on Jun 1st '25.Percheron acquired exclusive worldwide rights to HMBD-002 from Hummingbird Bioscience in June 2025, under an agreement that could provide the latter with up to USD 290 million in upfront and milestone payments, plus royalties on net sales.

NewsCallio Therapeutics, Inc. partners with Hummingbird Bioscience Pte. Ltd..In conjunction with the financing, Callio Therapeutics has entered into an exclusive worldwide license agreement with Hummingbird Bioscience for its multi-payload ADC platform in oncology, and associated intellectual property and pipeline assets, in exchange for equity, potential milestone payments and royalties.

NewsHummingbird Bioscience Pte. Ltd. hired Angèle Maki as Chief Business Officer on Dec 11th '23.Hummingbird Bioscience strengthens leadership team with appointment of Angèle Maki as Chief Business Officer.